Tiffany Gill
Major grant funding to progress lipid-based ...
Major grant funding to progress lipid-based therapies to treat prostate cancer
Tiffany Gill
Inaugural FCMHW Early Career Research Fellow at ...
Inaugural FCMHW Early Career Research Fellow at Flinders University - Jasmine Petersen
Tiffany Gill
Congratulations 2022 Honours Scholarship ...

Congratulations to the Centre’s 2022 Honours students on their scholarship awards and we wish them all the best for their research and training

Congratulations 2022 Honours Scholarship awardees
Publications, media release, Feature publication
Kelsey Long
Validation of a short form Male Depression Risk ...

Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men. Herreen D, Rice S, Zajac I. Brief assessment of male depression in clinical care:BMJ Open. 2022 Mar 28;12(3):e053650. doi: 10.1136/bmjopen-2021-053650.

Contact: Dr Ian Zajac

Validation of a short form Male Depression Risk Scale
Kelsey Long
The Women of the FCMHW - International Women's ...

To celebrate International Women’s Day, the Centre is highlighting some of the fantastic women of men’s health that have been supported by the Centre and are achieving great work in the field. FCMHW encourages and commends the involvement of women in men’s health and hopes to further support it in the future.

The Women of the FCMHW - International Women's Day

fatty acids

Inhibition of ceramide metabolism combats enzalutamide resistance in prostate cancer

Inhibition of ceramide metabolism combats enzalutamide resistance in prostate cancer

Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
Lin HM, Mak B, Yeung N, Huynh K, Meikle TG, Mellett NA, Kwan EM, Fettke H, Tran B, Davis ID, Mahon KL, Zhang A, Stockler MR, Briscoe K, Marx G, Crumbaker M, Stricker PD, Du P, Yu J, Jia S, Scheinberg T, Fitzpatrick M, Bonnitcha P, Sullivan DR, Joshua AM, Azad AA, Butler LM, Meikle PJ, Horvath LG.
EBioMedicine. 2021 Oct 14;72:103625. doi: 10.1016/j.ebiom.2021.103625. PMID: 34656931.
Contact: Lisa Butler

The role of the 6PGD protein in prostate cancer hormone treatment resistance

The role of the 6PGD protein in prostate cancer hormone treatment resistance

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth.
Gillis JL, Hinneh JA, Ryan NK, Irani S, Moldovan M, Quek LE, Shrestha RK, Hanson AR, Xie J, Hoy AJ, Holst J, Centenera MM, Mills IG, Lynn DJ, Selth LA, Butler LM. Elife. 2021 Aug 12;10:e62592. doi: 10.7554/eLife.62592. PMID: 34382934.
Contact: Luke Selth